Bruce C. Cozadd, Director at Jazz Pharmaceuticals plc (JAZZ), sold 6,000 shares at $190.22 ($1.1M) on 2026-04-01, disclosed to the SEC on 2026-04-03.
Scheduled sale ($1.1M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $190.22 | 3,684 | $701K | 61.3% |
| 2 | $190.94 | 2,292 | $438K | 38.3% |
| 3 | $191.74 | 24 | $5K | 0.4% |
| Total | $190.50 avg | 6,000 | $1.1M | 100% |
| Filing → |
| JAZZ | SELL | 2026-07-06 | $1.4M | — | Filing → |
| JAZZ | SELL | 2026-06-03 | $1.4M | — | Filing → |
| JAZZ | SELL | 2026-05-05 | $1.2M | — | Filing → |